Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98,685,316
-
Number of holders
-
203
-
Total 13F shares, excl. options
-
152,652,179
-
Shares change
-
+11,720,879
-
Total reported value, excl. options
-
$4,988,313,146
-
Value change
-
+$336,547,280
-
Put/Call ratio
-
1.79%
-
Number of buys
-
103
-
Number of sells
-
-106
-
Price
-
$32.68
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q4 2021
286 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q4 2021.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 152,652,179 shares
.
Largest 10 shareholders include Francisco Partners Management, LP (84,700,550 shares), MORGAN STANLEY (12,889,112 shares), Abdiel Capital Advisors, LP (8,062,788 shares), VANGUARD GROUP INC (6,050,865 shares), WELLINGTON MANAGEMENT GROUP LLP (3,864,141 shares), Silver Lake Group, L.L.C. (3,532,276 shares), TIGER GLOBAL MANAGEMENT LLC (2,345,000 shares), GOLDMAN SACHS GROUP INC (1,939,071 shares), Carmignac Gestion (1,828,119 shares), and Technology Crossover Management X, Ltd. (1,653,566 shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.